Cancer Center
Contact Data
Access verified oncologist, tumor board, pharmacy director, and executive contacts at 1,490 US cancer centers, from NCI-designated comprehensive cancer centers to community oncology programs. Every record NPI-validated and email-confirmed.
Trusted by Global Clients and Agencies
Who You Can Reach
What Each Record Includes
What Is Cancer Center Contact Data?
Quick Answer
Cancer center contact data is a verified directory of oncologists, tumor board members, pharmacy directors, and executives at US cancer treatment facilities. EmailAddress.ai covers 1,490 cancer centers including NCI-designated comprehensive cancer centers, NCI community cancer centers (NCCPs), and independent oncology practices, with contacts validated monthly against the NPI registry.
Cancer centers occupy two distinct tiers. The 72 NCI-designated comprehensive cancer centers conduct original research, set national treatment protocols through NCCN guidelines, and operate tumor boards that influence community oncology practice nationwide. Community cancer programs and independent oncology practices treat the majority of US cancer patients, making them the volume target for most pharma commercial teams.
Oncology drug launches depend on reaching the right contacts at the right facilities in the right sequence. At an NCI-designated center, the medical oncologist, tumor board chair, pharmacy director, and P&T committee all factor into formulary inclusion. At a community program, the lead oncologist and practice administrator often make the same decision together. EmailAddress.ai maps both tiers with contact-level detail and facility-level context.
Who Uses Cancer Center Contact Data
Oncology Drug Launch and Formulary Access
Pharma companies launching oncology drugs target cancer center pharmacy directors, P&T committees, and tumor board chairs for formulary inclusion and preferred agent status. At NCI-designated comprehensive cancer centers, NCCN guideline influence and tumor board endorsement drive broader market uptake. EmailAddress.ai maps those contacts by facility tier and NCI designation, so launch teams prioritize the centers with the highest protocol influence first.
Clinical Trial Site Identification and Investigator Outreach
Oncology CROs and pharma medical affairs teams identify principal investigators, sub-investigators, and research coordinators at cancer centers with active trial programs and relevant tumor type patient populations. NCI-designated centers have dedicated clinical research infrastructure; community cancer programs vary widely in trial capacity. EmailAddress.ai maps research program contacts alongside clinical oncology contacts so teams can qualify sites before outreach begins.
Radiation Oncology Equipment and Technology Sales
Radiation therapy equipment companies and treatment planning software vendors target radiation oncology department heads, medical physicists, and cancer center C-suite contacts for capital equipment decisions. Proton therapy installations, linear accelerator replacements, and adaptive radiation planning systems involve multi-million dollar purchase committees. EmailAddress.ai identifies the right contacts by cancer program type, facility size, and radiation oncology program status.
Medical Affairs and KOL Engagement
Pharma medical affairs teams use cancer center contact data to identify key opinion leaders, advisory board candidates, and publication-active oncologists at major academic cancer programs. NCI-designated centers concentrate the highest density of NCCN guideline authors, clinical trial leaders, and national conference faculty. EmailAddress.ai maps oncologist contacts by institution, tumor type specialty, and program designation to support KOL mapping and MSL call planning.
Frequently Asked Questions
How many cancer centers are in the US?
US cancer treatment takes place across more than 1,500 licensed cancer programs. EmailAddress.ai covers 1,490 cancer centers including NCI-designated comprehensive and clinical cancer centers, American College of Surgeons Commission on Cancer-accredited programs, and community oncology programs with significant treatment volume.
What oncology subspecialties are covered?
Coverage includes medical oncology by tumor type (breast, lung, GI, GU, CNS, hematologic malignancies), surgical oncology, radiation oncology, palliative care oncology, and pediatric oncology where applicable.
How are NCI-designated cancer centers different from community cancer programs?
NCI-designated centers are research-intensive academic programs that set clinical practice standards nationally. Community cancer programs are hospital-based or freestanding oncology programs serving local patient populations without the research mandate of NCI centers. EmailAddress.ai covers both with full contact data.
Can I filter cancer center contacts by tumor type specialization or NCI designation?
Yes. Contacts can be segmented by subspecialty (tumor type), NCI designation status, accreditation level, infusion volume, research program activity, geographic market, and facility affiliation.
What pharmacy contacts are available at cancer centers?
Coverage includes oncology pharmacy directors, clinical pharmacists specializing in oncology, infusion suite pharmacists, and P&T committee members with oncology formulary authority.
Get Verified Cancer Center Contact Data
Custom oncology lists by tumor type, NCI status, geography, and contact role.
Contact Sales